ATXI
:Avenue Therapeutics Inc *
Snapshot
|
Charting
|
News
|
Options
*
Deficient
:
Issuer Failed to Meet NASDAQ Continued Listing Requirements
$3.73
2.75%
$0.10
NASDAQ
8:30a ET
May 16 '24
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treat...
GlobeNewswire
Last
Change
Exchange
Market data is delayed by at least 15 minutes.
Markets
Portfolio
Symbol Lookup
Show me
Calls
Puts
Both
Options that expire in
Show All
No Options for ATXI
Market data provided by
News provided by